Teva Presents New Reslizumab Data at ERS International Congress 2015
September 27, 2015 at 06:38 AM EDT
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today presented results from a post hoc analysis of two pivotal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.